The authors' response
- PMID: 32999726
- PMCID: PMC7520020
- DOI: 10.1186/s40560-020-00493-w
The authors' response
Abstract
In response to comments raised, we acknowledge the shortcomings of our study. It is a small study. However, it is a pilot study, which is not meant to create generalizable data, rather to explore new potential directions. To this end, our conclusions were clearly supported by the results. We demonstrated that administration of 16.4% NaCl/Na-acetate solution was feasible, safe, and was associated with lower rates of AKI. We share the call that large RCTs are required to follow this pilot study and hope that our data will stimulate the ongoing discussion regarding the role of chloride in AKI mechanism.
Keywords: Acute kidney injury; Cerebral edema; Hyperchloremia; Hyperosmolar therapy; Neurocritical care; Subarachnoid hemorrhage.
© The Author(s) 2020.
Conflict of interest statement
Competing interestsThe authors declare that they have no competing interests.
Figures
References
-
- Sadan O, Singbartl K, Kraft J, et al. Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: the ACETatE (a low ChloriE hyperTonic solution for brain edema) randomized trial. J Intensive Care. 2020;8:32. doi: 10.1186/s40560-020-00449-0. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous